Advances in the computational landscape for repurposed drugs against COVID-19 is a research paper published in Drug Discovery Today (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U19AI117873
National Institutes of Health
Grant: 1U19AI117873-01
Modeling Early Immunity to Human Influenza Infection
NIAID NIH HHS
Grant: U19 AI117873
FWCI
4.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Additional file 1 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Additional file 2 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Additional file 2 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Additional file 3 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Additional file 3 of Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks